Product Information
CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7423 per GM under NDC 45802050901. Its NADAC has been published 289 times since Mar 24, 2021.
FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802050901
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202440FDA Approved
9/21/2015
TE Code
AB
On Market Since
2/3/2021
Price Statistics
The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 289 times since Mar 24, 2021, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7423 per GM |
|---|---|
| All-time high | $1.8527 (May 12, 2021) |
| All-time low | $0.6901 (Jun 17, 2026) |
| 52-week high | $0.8776 |
| 52-week low | $0.6901 |
| Median price | $0.8635 |
| Average price | $0.9809 |
| Largest weekly change | +35.1% (Jan 18, 2023) |
| Weeks tracked | 289 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin and benzoyl peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7423 per GM (NDC 45802050901), effective Sep 30, 2026.
How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 55.5%. It has been tracked across 289 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?
Since Mar 24, 2021, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.6901 (Jun 17, 2026) to a high of $1.8527 (May 12, 2021), with a median of $0.8635 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.5007 per GM — about 33% below CLINDAMYCIN-BENZOYL PEROX 1-5%.
Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?
CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 45802050901) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.